<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To describe a case of <z:chebi fb="0" ids="8502">propylthiouracil</z:chebi>-induced <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>, complicated with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> and <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Case report </plain></SENT>
<SENT sid="2" pm="."><plain>SETTING: Academic medical center </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENT: A 27-year-old man with a diagnosis of <z:hpo ids='HP_0100647'>Graves disease</z:hpo> developed multiple <z:hpo ids='HP_0002140'>ischemic strokes</z:hpo> 2 weeks after starting treatment with <z:chebi fb="0" ids="8502">propylthiouracil</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0040156" disease_type="Disease or Syndrome" abbrv="">Thyrotoxicosis</z:e> and abnormal hypercoagulable and rheumatological profiles were remarkable, with <z:hpo ids='HP_0003645'>prolonged partial thromboplastin time</z:hpo>, elevated anticardiolipin antibody level, and positive antinuclear antibody, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sj√∂gren</z:e> antibody, and anti-<z:chebi fb="0" ids="4705">double-stranded DNA</z:chebi> antibody test results, which were more than 8-fold greater than <z:mpath ids='MPATH_458'>normal</z:mpath> values </plain></SENT>
<SENT sid="5" pm="."><plain>No clinical manifestations of <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> were present </plain></SENT>
<SENT sid="6" pm="."><plain>INTERVENTION: Discontinuation of <z:chebi fb="0" ids="8502">propylthiouracil</z:chebi> and treatment with radioactive <z:chebi fb="60" ids="24859">iodine</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: <z:hpo ids='HP_0000836'>Hyperthyroidism</z:hpo> resolved and anti-<z:chebi fb="0" ids="4705">double-stranded DNA</z:chebi> antibodies returned to <z:mpath ids='MPATH_458'>normal</z:mpath> levels </plain></SENT>
<SENT sid="8" pm="."><plain>Eventually, <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> was diagnosed </plain></SENT>
<SENT sid="9" pm="."><plain>He was treated with oral anticoagulation and remained asymptomatic for 1 year of follow-up </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: In this young man with Graves <z:hpo ids='HP_0000836'>hyperthyroidism</z:hpo>, treatment with <z:chebi fb="0" ids="8502">propylthiouracil</z:chebi> was associated with transient autoimmune reactions suggestive of <z:e sem="disease" ids="C0263591" disease_type="Disease or Syndrome" abbrv="">drug-induced lupus</z:e>, <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, and <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>